These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 17037786)
21. Infliximab safety profile and long-term applicability in inflammatory bowel disease: clinical experiences from the eastern side of Europe. Molnár T; Farkas K; Nagy F; Szepes Z; Wittmann T Aliment Pharmacol Ther; 2010 May; 31(10):1152-3. PubMed ID: 20518754 [No Abstract] [Full Text] [Related]
22. Expanding possibilities in the treatment of patient groups with previously difficult-to-treat patients. Dörner T; Burmester GR Curr Opin Rheumatol; 2010 May; 22(3):235-6. PubMed ID: 20351494 [No Abstract] [Full Text] [Related]
23. Evaluation of the drug treatment regimens for inflammatory bowel disease. Brock EM; Zabihollah M Expert Opin Pharmacother; 1999 Nov; 1(1):15-8. PubMed ID: 11249558 [No Abstract] [Full Text] [Related]
35. [Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases]. Allez M Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):467-77. PubMed ID: 18448294 [No Abstract] [Full Text] [Related]
36. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia. Subrahmanyam P; Balakrishnan C; Dasgupta B Scand J Rheumatol; 2008; 37(3):239-40. PubMed ID: 18465465 [No Abstract] [Full Text] [Related]
37. Infliximab use in children and adolescents with inflammatory bowel disease. de Ridder L; Benninga MA; Taminiau JA; Hommes DW; van Deventer SJ J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):3-14. PubMed ID: 17592358 [TBL] [Abstract][Full Text] [Related]
38. Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapies. Van Assche G; Vermeire S; Rutgeerts P Gastroenterol Clin North Am; 2006 Dec; 35(4):743-56. PubMed ID: 17129811 [TBL] [Abstract][Full Text] [Related]
39. [Current medical treatment of inflammatory bowel disease]. Bosques-Padilla F Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494 [No Abstract] [Full Text] [Related]
40. [Biological drugs in the treatment of immunoinflammatory diseases]. Nielsen OH; Bendtzen K Ugeskr Laeger; 2008 Jun; 170(24):2103. PubMed ID: 18565288 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]